glp-1 antagonist receptor agonists show promise in treating substance use disorders Current Insights, Advantages and Challenges

The realistic caveat is that long-term maintenance without pharmacologic or procedural support is difficult for most people which is the entire reason the rest of this list exists

For more information about medications, consult our Medication Reference Guide

However, it's important to note that NICE guidelines for heart failure (NG106) and myocardial infarction do not currently recommend routine supplementation with either CoQ10 or L-carnitine, and these agents should not replace evidence-based pharmacological treatments

Only eight of the studies were with the new GLP-1 medications (semaglutide and tirzepatide)